ArticleActa pharmaceutica Sinica. B2025

Bispecific killer engager for targeted depletion of PD-1 positive lymphocytes: A new avenue for autoimmune disease treatment.

Lauren C Naatz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.